DOC Q1 2026 Earnings Massive EPS Beat Drives Strong Surprise Yet Stock Edges Lower NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline PEBK Q4 2025 Earnings Strong EPS Performance Amid Quiet Trading AIZN Q1 2026 Earnings Subordinated Notes Benefit as Core Earnings Surpass Estimates by 1127 Central Garden Pet CENT Q1 2026 Earnings Strong EPS Beat of 154 Drives Modest Stock Gains V Q1 2026 Earnings EPS Surges Past Estimates Revenue Data Pending